Glucagon-like peptide 2-(3-33) removes the first two and last residues, focusing analysis on the core GLP-2 region. The fragment is used to examine cleavage patterns, folding transitions, and receptor-binding determinants. Researchers apply it in structure-activity mapping of GLP-2 segments. Its defined truncation supports biophysical and mechanistic assessments.
CAT No: G16035
CAS No:275801-62-2
Synonyms/Alias:glucagon-like peptide 2-(3-33);275801-62-2;GLP-2 (3-33);GLP-2(3-33);GLXC-26361;DA-53589;
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
3. The spatiotemporal control of signalling and trafficking of the GLP-1R
5. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.